Stacy Feld
Head, Johnson & Johnson Innovation, West North America
Mill Valley, California
Invests in
Sectors:
Locations:
Min Investment:
$0.00Max Investment:
$0.00Target Investment:
$0.00
Skills
Education
Lists including Stacy
Investments
Work Experience
Head, Johnson & Johnson Innovation, West North America, Australia and New Zealand
2019
Head of Johnson & Johnson Innovation, West North America, Australia & New Zealand, located at the Innovation Center in South San Francisco, California. Leads team to build, advance, and manage a portfolio of co-investments and collaborations spanning the pharmaceutical, consumer health and medical device sectors. Responsible for expanding and nurturing external networks within the scientific, clinical and technology innovation communities, including with academia, venture capital investors, entrepreneurs and other governmental and private organizations.
Vice President, Consumer Venture Investments & External Innovation
2016
Global responsibility for scientific and technology-focused investment strategy for Consumer and Health Technology innovations. Responsible for management of Consumer external innovation portfolio for California Innovation Center.
Senior Director, Consumer Scientific Innovation
2014 - 2016
Co-creation and implementation of external innovation strategy to enhance the R&D pipeline for Johnson & Johnson Family of Consumer Companies. Identification and translation of novel science and technology across the external landscape into high-value business opportunities through partnership, investment and new venture creation.
2013 - 2014
Managing Member
2013 - 2014
Innovation strategy and business consulting in emerging areas of science and technology across the health, consumer products and healthcare landscape. Advisory roles included strategic business assessment, innovation strategy development, investment evaluation, financing strategy and technology scouting and opportunity development. Client base included global enterprises, start-up companies, entrepreneurs and venture funds.
2009 - 2014
Partner
2009 - 2014
Member of investment team focused on science- and technology-enabled solutions in health and sustainability sectors. Lead Personalized Health investment strategy, including landscaping, sourcing, evaluating, leading and managing investments, as well as authoring position papers, speaking at public events, mentoring entrepreneurs and judging venture competitions. Additional responsibilities for sector analyses and investment evaluation in therapeutics, medical device, clinical nutrition and consumer product sectors. Previous board responsibilities: T2 Biosystems (Director), Own Products (observer) and On-Q-ity (observer).
2004 - 2008
Associate Director, Business Development
2004 - 2008
Member of team of licensing professionals for leading biotechnology company focused on discovery, development and commercialization of novel therapies for treatment of high unmet medical needs. Led cross-functional team in conducting comprehensive diligence and business partnership discussions on 7 clinical-stage product opportunities and more than 10 preclinical opportunities in Immunology, Oncology, Metabolic Disease, Ophthalmology and Vascular Biology. Key leadership role in setting personalized health strategy, including establishment and leadership of cross-functional team for review, prioritization and evaluation of biomarker/diagnostic opportunities. Established in-licensing strategies to support internal R&D priorities in new and emerging growth areas.
2000 - 2003
Director of Licensing
2000 - 2003
Responsible for all licensing activities for publicly traded genomics and clinical diagnostics company (NASDAQ: TWTI). Established and implemented strategy for in-licensing intellectual property to support product development growth for research and clinical diagnostic businesses. Structured, negotiated and evaluated strategic alliances and collaborative agreements with customers, suppliers, distributors and strategic partners.
1998 - 2000
Intellectual Property Licensing Attorney
1998 - 2000
Commercial transactions group focused on structuring and negotiating strategic deals for technology clients. Practice focused primarily on general intellectual property counseling of biotechnology, diagnostic, pharmaceutical and other life science companies.